art_22__para_3__text_3 — Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16… · Lexiara

art_22__para_3__text_3

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

Upon receipt of the additional information, the Member State concerned shall complete its assessment within a maximum of 19 days.

← art_22__para_3__text_2 · All articles · art_22__para_3__text_4 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.